Summit Securities Group’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,880
Closed -$108K 991
2025
Q2
$108K Buy
+1,880
New +$151K 0.02% 350
2023
Q1
Sell
-325
Closed -$131K 780
2022
Q4
$131K Buy
+325
New +$152K ﹤0.01% 548

Other funds holding AGL

Summit Securities Group's AGL Position: Q3 2025 in Review

Summit Securities Group sold out of Agilon Health (AGL) in Q3 2025, closing a stake of 1,880 shares — an estimated $108K sold.

Summit Securities Group first reported a position in AGL in Q4 2022 and held it in 2 quarters. The position peaked at $131K in Q4 2022. 190 funds tracked by Wall St. Rank hold AGL as of Q3 2025.

  • Summit Securities Group reported no remaining Agilon Health position as of Q3 2025 after selling out during the quarter.
  • Summit Securities Group sold 1,880 Agilon Health shares in Q3 2025, an estimated $108K.
  • Summit Securities Group first reported a position in Agilon Health in Q4 2022 and held it in 2 quarters.
  • Summit Securities Group's Agilon Health position peaked at $131K in Q4 2022.
  • 190 funds tracked by Wall St. Rank held Agilon Health as of Q3 2025.

Based on Summit Securities Group's 13F filing for Q3 2025, filed 13 Nov 2025.